Annovis Bio Inc. (ANVS)
NYSE: ANVS
· Real-Time Price · USD
2.73
0.01 (0.37%)
At close: Aug 15, 2025, 3:59 PM
2.72
-0.37%
After-hours: Aug 15, 2025, 05:59 PM EDT
Annovis Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.22B | -5.54M | -5.86M | -12.64M | -5.02M | -1.07M | -22.21M | -6.43M | -9.54M | -9.74M | -3.09M | -7.62M | -8.72M | -5.89M | -5.91M | -2.85M | -2.52M | -3.2M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 496.62M | 499.89K | 1.48M | 393.08K | 1.6M | 364.76K | 882.38K | 632.19K | 1.57M | 1.54M | 1.46M | 2.36M | 1.9M | 3.43M | 3.88M | 785.94K | 7.99K | 23.98K |
Other Working Capital | n/a | -1.57M | -1.37M | -3.89M | 3.53M | -2.45M | 762.39K | 3.96M | 1.34M | -3.62M | -4.09M | 334.41K | 146.94K | -803.44K | -132.73K | 138.95K | 86.78K | 218.12K |
Other Non-Cash Items | 617.55M | -558K | -743.94K | 12.23M | -2.77M | -6.7M | 11.84M | -5.35M | 4.55M | 1.35M | -657.75K | 1.41M | 1.93M | 3.19M | 3.48M | 606.03K | 722.73K | -458.73K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -2.5M | -3.16M | -3.18M | 2.81M | 368.12K | 128.83K | 4.71M | -1.64M | -3.43M | -1.97M | 1.28M | 119.78K | -562.52K | 265.61K | 318.87K | -627.95K | 700.83K |
Operating Cash Flow | -5.11B | -8.1M | -8.29M | -3.2M | -3.38M | -7.03M | -9.36M | -6.43M | -9.61M | -11.63M | -3.61M | -3.99M | -6.69M | -3.02M | -1.77M | -1.74M | -3.14M | -2.47M |
Capital Expenditures | n/a | 4.00 | -4 | n/a | 5.00 | n/a | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.46 | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 7.48M | n/a | 540K | 450K | n/a | 1K | 7.39K | 4.61M | n/a | n/a | 4.61K | 95.01M | n/a | 92.08K | 3.02K |
Financial Cash Flow | n/a | 19.78M | 6.2M | 11.84M | 4.24M | 4.42M | 8.76M | n/a | 8.57M | 7.39K | 4.61M | n/a | n/a | 4.61K | 46.7B | -25.46K | 46.77M | 3.02K |
Net Cash Flow | -5.11B | 11.68B | -2.08M | 8.64M | 860.8K | -2.62M | -600.22K | -22.16M | -1.03M | -11.62M | -3.61M | -3.99M | -6.69M | -3.02M | -1.77M | -1.77M | 43.62M | -2.47M |
Free Cash Flow | -5.11B | -8.1B | -8.29M | -3.2M | -3.38M | -7.03M | -9.36M | -6.43M | -9.61M | -11.63M | -3.61M | -3.99M | -6.69M | -3.02M | -1.77M | -1.74M | -3.14M | -2.47M |